市场调查报告书
商品编码
1492681
体外循环系统市场:按产品类型、应用和最终用户划分 - 全球预测 2024-2030Extracorporeal Circulation System Market by Product (Blood Filters, Cannulae, Heart-Lung Machines), Type (Bench Top, Portable), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年体外循环系统市场规模为13.5亿美元,预计2024年将达14.6亿美元,2030年将达23.4亿美元,复合年增长率为8.11%。
体外循环系统(ECS)是医疗设备,用于暂时支持和取代患者的自然循环功能。它接管心臟和肺部的作用,为体外患者的血液提供氧气,维持全身的血液循环。这确保了重要器官能够持续获得富氧血液的供应,即使心臟在手术过程中无法运作。该技术有助于减轻手术期间心臟的压力,并为外科医生执行复杂手术提供受控环境。全球心血管疾病的增加导致对心血管手术的需求增加,增加了对 ECS 的需求。此外,医疗基础设施的扩张和医疗设施的投资也对市场扩张做出了重大贡献。然而,ECS 设备的高昂成本和相关营运费用可能会让一些医疗机构望而却步,尤其是在欠发达和发展中地区。操作 ECS 的复杂性需要训练有素的专业人员,这在缺乏医学教育和培训基础设施的地区可能会成为障碍。此外,ECS 技术的创新可提高外科手术的安全性和有效性,也是市场成长的主要机会。最大限度地减少併发症并改善患者治疗效果的设计和功能改进尤其具有影响力。
主要市场统计 | |
---|---|
基准年[2023] | 13.5亿美元 |
预测年份 [2024] | 14.6亿美元 |
预测年份 [2030] | 23.4亿美元 |
复合年增长率(%) | 8.11% |
区域洞察
全球体外循环系统市场以美洲为主,其中美国凭藉其强大的医疗体系、高昂的医疗成本以及大型医疗设备公司的强大影响力而处于领先地位。加拿大是一个由政府资助的医疗保健系统和对医学研究的承诺所驱动的市场。该地区的重点是技术先进、高效和安全的医疗解决方案。欧洲是体外循环系统的强大市场,其特点是广泛的研发活动,特别是在欧盟国家。该市场受益于完善的医疗保健体系和严格的监管标准,可确保高品质的医疗设备。在中东,医疗保健投资的增加和尖端医疗技术的引入正在推动市场成长。目前非洲市场规模较小,但由于医疗基础设施改善和国际投资,逐渐成长。在医疗保健成本上升、心血管疾病盛行率增加以及医疗保健基础设施加强的推动下,亚太地区的体外循环系统市场正在显着成长。中国因其庞大的患者人数和不断增长的医疗旅游业而在该地区处于领先地位。在日本,技术进步和强大的政府医疗保健政策正在推动市场发展。在印度,由于人们对先进治疗方法的认识不断增强以及私营部门对医疗保健的投资增加,市场正在扩大。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在体外循环系统市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对体外循环系统市场供应商的现状进行深入而详细的评估。对供应商贡献的彻底比较和分析可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该细分市场竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以更好地参与市场竞争。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对体外循环系统市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[184 Pages Report] The Extracorporeal Circulation System Market size was estimated at USD 1.35 billion in 2023 and expected to reach USD 1.46 billion in 2024, at a CAGR 8.11% to reach USD 2.34 billion by 2030.
An extracorporeal circulation system is a medical device used primarily in surgeries to support and replace the patient's natural circulatory function temporarily. The device takes over the role of the heart and lungs by oxygenating the blood outside the patient's body and maintaining the circulation of blood throughout the body. This ensures that vital organs receive a continuous supply of oxygen-rich blood despite the heart not functioning during the surgery. This technology helps reduce the strain on the heart during surgery and offers a controlled environment for the surgeon to perform complex procedures. Rising incidences of cardiovascular diseases globally lead to higher demand for cardiac surgeries, thereby driving the need for ECS. Additionally, expansion in healthcare infrastructure and investments in medical facilities contribute significantly to market expansion. However, the high cost of ECS equipment and the operation expenditure involved can be prohibitive for some institutions, particularly in underdeveloped and developing regions. The complexity of operating ECS necessitates highly trained professionals, which might be a barrier in regions lacking in medical education and training infrastructure. Furthermore, innovation in ECS technology, which increases the safety and efficacy of surgical procedures, is a significant opportunity for market growth. Improved designs and functionalities that minimize complications and enhance patient outcomes are particularly influential.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.35 billion |
Estimated Year [2024] | USD 1.46 billion |
Forecast Year [2030] | USD 2.34 billion |
CAGR (%) | 8.11% |
Regional Insights
The Americas dominate the global extracorporeal circulation system market, with the United States leading due to its robust healthcare system, high healthcare spending, and strong presence of leading medical device companies. Canada's market is driven by its government-funded healthcare system and initiatives in medical research. The region shows a high emphasis on technologically advanced, efficient, and safe healthcare solutions. Europe is a strong market for extracorporeal circulation systems, characterized by extensive research and development activities, particularly in EU countries. The market benefits from well-established healthcare systems and stringent regulatory standards ensuring high-quality medical devices. In the Middle East, the market growth is fueled by rising healthcare investment and the adoption of cutting-edge medical technologies. Africa is currently a smaller market but is gradually growing due to improved healthcare infrastructure and international investment. The APAC region is noticing significant growth in the extracorporeal circulation systems market, driven by increasing healthcare expenses, growing prevalence of cardiovascular diseases, and enhanced healthcare infrastructure. China is leading the region due to its large patient population and growing medical tourism. In Japan, advancements in technology and strong government healthcare policies are propelling the market. India's market is expanding due to rising awareness about advanced treatment methods and increasing private sector investments in healthcare.
Market Insights
The market dynamics represent an ever-changing landscape of the Extracorporeal Circulation System Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Extracorporeal Circulation System Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Extracorporeal Circulation System Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
FDA Approves LivaNova's LifeSPARC System for ECMO Use
LivaNova PLC, a leader in medical technology, announced that its LifeSPARC Advanced Circulatory Support system has received FDA 510(k) clearance for use in extracorporeal membrane oxygenation (ECMO). The clearance comes after successful integration of real-world evidence, including data from the COVID-19 pandemic. The LifeSPARC system is designed to enhance patient support during severe cardiac and respiratory failure. This approval marks a significant step in its deployment across healthcare settings. [Published On: 2022-11-17]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Extracorporeal Circulation System Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Extracorporeal Circulation System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK, Boston Scientific, CardioFocus, Edwards Lifesciences, EUROSETS S.r.l., LivaNova PLC, Maquet Holding B.V. & Co. KG by Getinge Group, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, OriGen Biomedical, Inc., Philips Healthcare, Siemens Healthineers, Terumo Corporation, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA.
Market Segmentation & Coverage